Keyphrases
Sulfatide
100%
Extracellular Vesicles
100%
Multiple Sclerosis Treatment
100%
Demyelinating Neuropathy
100%
Anti-neurofascin Antibody
100%
Multiple Sclerosis
83%
Healthy Controls
50%
Small Extracellular Vesicles
50%
HLA-DRB1*1501
28%
Facial Diplegia
25%
MHC Class I
16%
MHC Class II
16%
Pathological Conditions
16%
Biological Function
16%
Glycolipids
16%
Disease Response
16%
Potential Biomarkers
16%
Intercellular Communication
16%
Nanovesicles
16%
Exosomal
16%
Pathological Changes
16%
Development Course
16%
Nucleic Acids
16%
Particle Size Distribution
16%
Recipient Cells
16%
Disease Course
16%
Response to Treatment
16%
Alix
16%
Lipids
16%
Cellular Origin
16%
Nanoparticle Tracking Analysis
16%
Biological Fluids
16%
Plasma-derived Extracellular Vesicles
16%
Biological Significance
16%
NF155
16%
Paranodal Proteins
16%
Nodal Protein
16%
Membrane Organization
16%
Protein Content
16%
High Performance Liquid Chromatography-tandem Mass Spectrometry (HPLC-MS/MS)
16%
Disease Development
16%
Early Adjustment
12%
Neuroscience
Protein Kinase LKB1
100%
Central Nervous System
100%
White Matter Disease
100%
Nervous System Disorder
50%
Peripheral Nervous System
50%
Demyelinating Disorder
50%
Transverse Myelitis
50%
Myelitis
50%
Western Blot
50%
Spinal Cord Disease
50%
Upper Motor Neuron
50%
Multiple Sclerosis
50%
Magnetic Resonance Imaging
50%
Immunoglobulin M
50%
Polyneuropathy
50%
Lower Motor Neuron
50%
Autoantibodies
50%
Glycolipid
16%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Demyelinating Neuropathy
100%
Protein Kinase LKB1
100%
Progressive Multifocal Leukoencephalopathy
100%
Acute Inflammatory Demyelinating Polyneuropathy
25%
Rheumatology
12%
Immunosuppressive Drug
12%
Central Nervous System Disease
12%
Brain Biopsy
12%
Early Diagnosis
12%
Magnetic Resonance Imaging of Brain
12%
JC Virus
12%
Brain Tissue
12%
Organ Transplantation
12%
Immune Reconstitution
12%
Immunity
12%
Immune Deficiency
12%
Oncology
12%